Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Benzocaine for Pain in Acute Otitis Media
NCT03116737Phase 3Completed
- Sponsor
- Lachlan Pharma Holdings Unlimited Company
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute otitis media (AOM) comparing Benzocaine Otic Solution with Placebo (2 arms). Primary endpoint: Summed Pain Intensity Difference Assessed by Faces Pain Scale-Revised (FPS-R) at 60 minutes. Started Jan 2017; status: completed.
02
Drugs
benzocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT03116737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116737.